Latest News

Yesterday
Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie? Zacks18:44 15-May-26
See Which Recent 13F Filers Hold ABBV But Odyssean and Neo Ivy Capital Management Exited Nasdaq18:25 15-May-26
How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results? Zacks17:02 15-May-26
In the last 7 days
BeiGene Must Face AbbVie's Chemical Trade Secret Claims Law36022:20 14-May-26
BeiGene Can’t Toss AbbVie Trade Secrets Suit Over Cancer Therapy Bloomberg Law00:02 14-May-26
The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio Zacks12:19 13-May-26
Top Stock Reports for NVIDIA, Mastercard & AbbVie Zacks22:34 12-May-26
3 Reasons to Buy AbbVie Stock (ABBV) Like There's No Tomorrow The Motley Fool15:58 12-May-26
Stock Watch: US Pharma Rescues Earnings Season As Lilly, AbbVie And BMS Beat Scrip Pharma Intelligence11:46 12-May-26
A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried? The Motley Fool22:50 11-May-26
AbbVie Mayo employee honoured with major women in pharma award The Mayo News16:53 11-May-26
AbbVie Stock: Is Wall Street Bullish or Bearish? Barchart13:01 11-May-26
In the last month
Is AbbVie (ABBV) Still Worth Considering After Recent Share Price Pullback? Simply Wall St22:59 8-May-26
AbbVie’s Skyrizi beats out J&J’s Tremfya in in April drug ad spending leaderboard FiercePharma15:09 8-May-26
AbbVie Korea holds ovarian cancer awareness campaign on World Ovarian Cancer Day Korea Biomedical Review04:54 8-May-26
AbbVie Delivers Strong Q1 Earnings Beyond Humira. This Dividend King Still Shines. Barchart20:01 7-May-26
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? The Motley Fool21:11 6-May-26
AbbVie to Present at the Bank of America Securities Healthcare Conference PR Newswire (Press Release)13:03 6-May-26
S&P 500 Analyst Moves: ABBV Nasdaq19:06 5-May-26
AbbVie Achieves #77 Analyst Rank, Surpassing Ball Nasdaq19:06 5-May-26
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? Zacks15:08 5-May-26
Zifo's SiEE Boston Summit Charts New Roadmap for 'Practical AI' in Life Sciences, Bridging the… PR Newswire (Press Release)14:09 5-May-26
Clio Health Champions: Madhuri Shah, Head of Marketing – Vyalev, AbbVie Muse by Clio14:02 5-May-26
AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel… PR Newswire (Press Release)13:07 5-May-26
AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook The Motley Fool21:52 4-May-26
AbbVie Regulatory Submission and Deal News JD Supra18:03 4-May-26
US FDA declines to approve AbbVie's wrinkle treatment due to manufacturing concerns (April 23) The Tribune, California17:49 4-May-26
Should AbbVie’s (ABBV) Immunology Strength and Raised Outlook Offset Earnings Dip for Investors? Simply Wall St02:56 30-Apr-26
AbbVie's patent on immunology therapy rejected The Times of India01:37 30-Apr-26
AbbVie Thrives on New Drug Demand ShareCafe22:51 29-Apr-26
AbbVie Is Looking To Business Development To Backstop I&I Strength Scrip Pharma Intelligence22:14 29-Apr-26
AbbVie Earnings: Immunology Portfolio and Pipeline Look Solid MorningStar.com20:40 29-Apr-26
AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde FiercePharma19:58 29-Apr-26
AbbVie Thanks 'Excellent Start To 2026' To Immunology And Neuroscience Strength Benzinga19:55 29-Apr-26
AbbVie Seeks Early Win Over HHS In Botox Drug Price Suit Law36019:11 29-Apr-26
ABBV Beats on Q1 Earnings & Sales, Raises '26 EPS View Zacks17:35 29-Apr-26
AbbVie (ABBV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates Zacks17:04 29-Apr-26
AbbVie (ABBV) Tops Q1 Earnings and Revenue Estimates Zacks15:22 29-Apr-26
AbbVie’s (NYSE:ABBV) Q1 CY2026 Sales Top Estimates Barchart13:23 29-Apr-26
AbbVie Reports First-Quarter 2026 Financial Results PR Newswire (Press Release)12:47 29-Apr-26
AbbVie Seeks FDA Approval To Expand Rinvoq Use For Alopecia Areata RTT News08:37 29-Apr-26
Curogen, Epibiotech win 1st AbbVie-KHIDI biotech award Korea Biomedical Review03:13 29-Apr-26
AbbVie, Roche cut donations despite strong revenue growth in Korea in 2025 Korea Biomedical Review02:20 29-Apr-26
AbbVie Seeks Pan-KRAS Position With Kestrel Financing And Option Deal Scrip Pharma Intelligence22:29 28-Apr-26
Should You Buy AbbVie Stock Hand Over Fist Before April 29? The Motley Fool17:28 28-Apr-26
AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata AbbVie (Press Release)13:02 28-Apr-26
AbbVie's Planned $1B-Plus Research Triangle Campus Development Buoys Improved Life Sciences Outlook Bisnow23:03 27-Apr-26
AbbVie Submits Regulatory Application to FDA for SKYRIZI® (risankizumab-rzaa) Subcutaneous… PR Newswire (Press Release)13:05 27-Apr-26
AbbVie Announces $1.4 Billion North Carolina Campus To Expand U.S. Pharmaceutical Manufacturing … Pharmaceutical Online13:04 27-Apr-26
AbbVie's TrenibotE Receives FDA CRL Due to Manufacturing Issues Zacks18:29 24-Apr-26
FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs FiercePharma16:49 24-Apr-26
Insights Into AbbVie (ABBV) Q1: Wall Street Projections for Key Metrics Zacks15:25 24-Apr-26
AbbVie Faces FDA Rejection On Manufacturing Issues For Wrinkle Drug Benzinga13:52 24-Apr-26
FDA declines to approve AbbVie's Botox follow-up pharmaphorum11:25 24-Apr-26
AbbVie expands US footprint with new $1.4 billion manufacturing campus European Pharmaceutical Review11:23 24-Apr-26
15 Press Releases You Need to See This Week PR Newswire (Press Release)11:06 24-Apr-26
AbbVie's largest-ever capital investment of $1.4 B to build pharma manufacturing campus in US BioSpectrum Asia08:23 24-Apr-26
AbbVie: FDA Issues Crl For TrenibotulinumtoxinE Related To Manufacturing Processes RTT News06:34 24-Apr-26
AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the … PR Newswire (Press Release)21:05 23-Apr-26
AbbVie Q1 Earnings Loom: Buy or Sell the Stock Ahead of Results? Zacks15:19 23-Apr-26
AbbVie opts for North Carolina to house $1.4bn manufacturing site Pharmaceutical Technology11:29 23-Apr-26
AbbVie makes record investment in North Carolina plant pharmaphorum09:38 23-Apr-26
Pharma giant AbbVie picks Durham for $1.4 billion investment with hundreds of jobs News & Observer, North Carolina18:52 22-Apr-26
AbbVie to establish NC production base with $1.4B investment, creating 730-plus jobs FiercePharma18:51 22-Apr-26
Pharma giant AbbVie picks Durham for $1.3 billion investment with hundreds of jobs News & Observer, North Carolina17:51 22-Apr-26
Governor Stein Announces AbbVie to Build a New $1.4 Billion Manufacturing Campus in Durham Office of the North Carolina Governor (Press Release)17:25 22-Apr-26
AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus PR Newswire (Press Release)17:06 22-Apr-26
Should You Forget Pfizer and Buy This Pharma Stock Instead? The Motley Fool16:58 22-Apr-26
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know Zacks15:00 22-Apr-26
UChicago Medicine marks one-year countdown to opening of AbbVie Foundation Cancer Pavilion Newswise (Press Release)19:59 21-Apr-26
Santen bags China rights to 5 glaucoma drugs from AbbVie BioSpectrum Asia12:10 21-Apr-26
Here's Why AbbVie (ABBV) Fell More Than Broader Market Zacks23:50 20-Apr-26
Will AbbVie's Oncology Franchise Weigh on Q1 Top-line Growth? Zacks14:39 20-Apr-26
AbbVie launches ‘PSO Done’ psoriasis campaign with cross-agency effort FiercePharma13:07 20-Apr-26
Nxera Secures $10 Million Milestone From AbbVie RTT News09:04 20-Apr-26
The Zacks Analyst Blog Microsoft, AbbVie, BHP, CBL & Associates Properties and IRIDEX Zacks08:32 20-Apr-26
Top Analyst Reports for Microsoft, AbbVie & BHP Zacks23:27 17-Apr-26
AbbVie Trades Below 50-Day and 200-Day SMA: How to Play the Stock Zacks18:01 17-Apr-26
More Drugmakers Join TrumpRx Dermatology Advisor16:48 17-Apr-26
Why AbbVie Is a No-Brainer Stock to Buy on the Dip The Motley Fool21:02 16-Apr-26

      
            
      
    view more headlines
   
      
      
      
15 May 18:44
   
AbbVie News

NewsNow aims to be the world's most accurate and comprehensive aggregator of AbbVie news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
AbbVie

Latest News

AbbVie News

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories
